ProHeart 12 (moxidectin) extended-release injectable suspension for dogs 12 months of age and older for the prevention of heartworm disease caused by Dirofilaria immitis for 12 months had been approved by the FDA. ProHeart 12 is also approved for the treatment of existing larval and adult hookworm infections.
Source: FDA, July 2, 2019. Link. The ProHeart® 12 formulation is the same as the previously approved product (ProHeart® 6) but contains three times the concentration of moxidectin, resulting in a 12-month duration of action.
Also see: ProHeart® 12 (moxidectin), Zoetis, April 2019. Link.
INSIGHTS: Congratulations to Zoetis on this approval and the potential year-round compliance increases in heartworm prevention.